Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reading Rheum

Maripat Corr, MD  |  Issue: December 2007  |  December 1, 2007

These studies underscore the potential importance of intracellular signaling in the pathogenesis of autoimmune disease. Traf1 mediates signal transduction through TNF receptors, and Stat 4 is a key transcription factor that transmits signals from pro-inflammatory cytokines including IL-12 and IL-23. Although there is compelling biologic data on the roles of these cytokines and complement in RA, these genetic studies are presented without any functional data. Future studies will therefore need biochemical evaluation of the influence of these variants on protein expression and function. These studies also provide intriguing hints to overlapping mechanisms in diseases like RA and SLE, which have both distinctive and mutual features. However, whether the propensity to generate specific autoantibodies (i.e. anti–CCP) is genetically determined remains to be fully elucidated. Eventually, the use of individual genetic profiles could lead to customized treatment to target defective or overactive pathways to maximize efficacy and minimize side effects.

References

  1. Wordsworth BP, Salmon M. The HLA class II component of susceptibility to RA. Baillieres Clin Rheumatol. 1992;6:325-336.
  2. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with RA. Am J Hum Genet. 2004;75:330-337.
  3. Seidl C, Donner H, Fischer B, et al. CTLA4 codon 17 dimorphism in patients with RA. Tissue Antigens. 1998;51:62-66.
  4. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with RA. Nat Genet. 2003;34:395-402.
  5. Amos CI, Chen WV, Lee A, et al. High-density SNP analysis of 642 Caucasian families with RA identifies two new linkage regions on 11p12 and 2q33. Genes Immun. 2006;7:277-286.
  6. Gray-McGuire C, Moser KL, Gaffney PM, et al. Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet. 2000;67:1460-1469.
  7. Cantor RM, Yuan J, Napier S, et al. Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum. 2004;50:3203-3210.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Clinical researchGenetic researchLupusReading RheumRheumatoid Arthritis (RA)

Related Articles

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

    Translating Genetic Discoveries into Rheumatic Therapies

    March 18, 2018

    SAN DIEGO—Will rheumatologists soon be able to use data from genetics and genome-wide association studies to more accurately predict disease and develop new therapies for rheumatic diseases? At a Nov. 5 session at the 2017 ACR/ARHP Annual Meeting, experts shared their views on how to glean this useful knowledge from genomics studies. The cost to develop…

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

    Research Across the Spectrum

    September 1, 2009

    NIAMS director highlights innovative research initiatives

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences